Cargando…
Alterations in platelets during SARS-CoV-2 infection
Coronavirus disease 2019 (COVID-19) is a pandemic syndrome caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. SARS-CoV-2 infection induces a process of inflammation and thrombosis supported by an altered platelet activation state. This platelet activation is peculiar b...
Autores principales: | Brambilla, Marta, Canzano, Paola, Becchetti, Alessia, Tremoli, Elena, Camera, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425443/ https://www.ncbi.nlm.nih.gov/pubmed/34384321 http://dx.doi.org/10.1080/09537104.2021.1962519 |
Ejemplares similares
-
Different Contribution of Monocyte- and Platelet-Derived Microvesicles to Endothelial Behavior
por: Brambilla, Marta, et al.
Publicado: (2022) -
Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study
por: Trabattoni, Daniela, et al.
Publicado: (2022) -
Impact of angiotensin-converting enzyme inhibition on platelet tissue factor expression in stroke-prone rats
por: Brambilla, Marta, et al.
Publicado: (2018) -
Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients
por: Camera, Marina, et al.
Publicado: (2022) -
Head-to-Head Comparison of Tissue Factor-Dependent Procoagulant Potential of Small and Large Extracellular Vesicles in Healthy Subjects and in Patients with SARS-CoV-2 Infection
por: Brambilla, Marta, et al.
Publicado: (2023)